Avidity Biosciences Inc Live Stock Price Today, Share Analysis and Chart

Name: Avidity Biosciences Inc: Is Infosys Ltd. worth buying?
Item: Avidity Biosciences Inc
Rating: 1.65483325
Author: Trendlyne DVM scores

about

Avidity Biosciences Inc is a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates, or AOCs. Company's pipeline currently has three programs in potentially registrational clinical...

41.44 1.22 (3.03%)

26.00% Fall from 52W High

3.4M

XNAS Volume

XNAS 16 Sep, 2025 5:30 PM (EDT)

Not Eligible

Expensive Valuation

6.3 / 100

Technically Neutral

59.9 / 100

1Yr Price target upside is 66%

18 analysts

Avidity Biosciences Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Avidity Biosciences Inc Live Stock Price Today, Share Analysis and Chart

Avidity Biosciences Inc is a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates, or AOCs. Company's pipeline currently has three programs in potentially registrational clinical...

26.00% Fall from 52W High

SWOT Analysis

Avidity Biosciences Inc Live Price Chart